
FC
Franklin Covey Co
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
20.330
Open
20.200
VWAP
19.82
Vol
186.89K
Mkt Cap
249.04M
Low
19.580
Amount
3.71M
EV/EBITDA(TTM)
6.97
Total Shares
13.27M
EV
217.69M
EV/OCF(TTM)
5.32
P/S(TTM)
0.93
Franklin Covey Co. is a global content and solutions company focused on individual and organizational performance improvement. The Company provides professional services in 150 countries and territories around the world. Its segments include North America, International Direct Offices, International Licenses, Education Practice, and Corporate and Other. The North America segment offers organizations to solve the problems that require changes in human behavior, including leadership, productivity, execution, trust, and sales performance. This segment includes sales personnel and operations that serve the United States and Canada. The International Licensees segment is primarily comprised of its international licensee’s royalty revenues. The Education Practice segment includes its domestic and international education practice operations. The Corporate and other information includes leasing operations, shipping and handling revenues, royalty revenues from Franklin Planner Corp.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q2
FY2026Q1
FY2025Q4
63.20M
+6.02%
--
--
71.67M
+3.74%
--
--
80.38M
-4.45%
--
--
Estimates Revision
The market is revising Downward the revenue expectations for Franklin Covey Co. (FC) for FY2025, with the revenue forecasts being adjusted by -3.47% over the past three months. During the same period, the stock price has changed by -4.32%.
Revenue Estimates for FY2025
Revise Downward

-3.47%
In Past 3 Month
Stock Price
Go Down

-4.32%
In Past 3 Month
3 Analyst Rating

67.51% Upside
Wall Street analysts forecast FC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FC is 33.00 USD with a low forecast of 27.00 USD and a high forecast of 37.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
0 Hold
0 Sell
Strong Buy

67.51% Upside
Current: 19.700

Low
27.00
Averages
33.00
High
37.00

67.51% Upside
Current: 19.700

Low
27.00
Averages
33.00
High
37.00
Roth Capital
Buy
downgrade
$30 -> $27
2025-07-07
Reason
Roth Capital
Price Target
$30 -> $27
2025-07-07
downgrade
Buy
Reason
Roth Capital lowered the firm's price target on Franklin Covey to $27 from $30 and keeps a Buy rating on the shares after its Q3 results and updated outlook last week. The firm cites the company having issued its second downward revision to FY25 guidance in two quarters. Roth adds that Franklin Covey's challenging market conditions contrast with the reorganized go-to-market strategy, which the firm believes will yield improvement in long-term growth potential.
Northland
Nehal Chokshi
Outperform -> NULL
downgrade
$60 -> $37
2025-07-03
Reason
Northland
Nehal Chokshi
Price Target
$60 -> $37
2025-07-03
downgrade
Outperform -> NULL
Reason
Northland analyst Nehal Chokshi lowered the firm's price target on Franklin Covey to $37 from $60 and keeps an Outperform rating on the shares. The leading indicator of subscription invoice value growth worsened to an 8% year over year decline, though management continues to see green shoots with go to market transformation as evidenced by aggressive pace of buybacks, the analyst tells investors in a research note.
Barrington Research
Alexander Paris
Buy
Maintains
$35
2025-04-10
Reason
Barrington Research
Alexander Paris
Price Target
$35
2025-04-10
Maintains
Buy
Reason
Barrington lowered the firm's price target on Franklin Covey to $35 from $45 and keeps an Outperform rating on the shares. The firm views the company's strategic growth investments and their impact on near-term earnings as "an appropriate trade-off for accelerated growth and profitability in the intermediate to long term," but given lower near-term revenue and earnings expectations it would expect "a sharp sell-off in the shares this morning once the market opens." However, Barrington recommends that investors consider taking advantage of the weakness to establish or add to positions.
Barrington Research
Alexander Paris
Buy
Maintains
$45 → $35
2025-04-03
Reason
Barrington Research
Alexander Paris
Price Target
$45 → $35
2025-04-03
Maintains
Buy
Reason
Barrington lowered the firm's price target on Franklin Covey to $35 from $45 and keeps an Outperform rating on the shares. The firm views the company's strategic growth investments and their impact on near-term earnings as "an appropriate trade-off for accelerated growth and profitability in the intermediate to long term," but given lower near-term revenue and earnings expectations it would expect "a sharp sell-off in the shares this morning once the market opens." However, Barrington recommends that investors consider taking advantage of the weakness to establish or add to positions.
Barrington Research
Alexander Paris
Buy
Maintains
$45
2025-03-21
Reason
Barrington Research
Alexander Paris
Price Target
$45
2025-03-21
Maintains
Buy
Reason
Barrington Research
Alexander Paris
Buy
Maintains
$45
2024-11-07
Reason
Barrington Research
Alexander Paris
Price Target
$45
2024-11-07
Maintains
Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Franklin Covey Co (FC.N) is 24.35, compared to its 5-year average forward P/E of 56.98. For a more detailed relative valuation and DCF analysis to assess Franklin Covey Co 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
56.98
Current PE
24.35
Overvalued PE
128.44
Undervalued PE
-14.47
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Undervalued
5Y Average EV/EBITDA
12.14
Current EV/EBITDA
7.19
Overvalued EV/EBITDA
15.70
Undervalued EV/EBITDA
8.58
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Strongly Undervalued
5Y Average PS
1.87
Current PS
0.96
Overvalued PS
2.29
Undervalued PS
1.44
Financials
Annual
Quarterly
FY2025Q3
YoY :
-8.52%
67.12M
Total Revenue
FY2025Q3
YoY :
-71.96%
2.54M
Operating Profit
FY2025Q3
YoY :
-124.63%
-1.41M
Net Income after Tax
FY2025Q3
YoY :
-125.58%
-0.11
EPS - Diluted
FY2025Q3
YoY :
-52.63%
2.77M
Free Cash Flow
FY2025Q3
YoY :
-0.66%
73.32
Gross Profit Margin - %
FY2025Q3
YoY :
-19.03%
10.72
FCF Margin - %
FY2025Q3
YoY :
-126.92%
-2.10
Net Margin - %
FY2025Q3
YoY :
-100.00%
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 180.11% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
FC News & Events
Events Timeline
2025-07-03 (ET)
2025-07-03
12:00:02
Franklin Covey falls -10.4%

2025-07-03
10:00:02
Franklin Covey falls -9.2%

2025-07-02 (ET)
2025-07-02
16:12:01
Franklin Covey cuts FY25 revenue view to $265M-$275M, consensus $276.55M

Sign Up For More Events
Sign Up For More Events
News
4.0
07-07TipRanks3 Best Stocks to Buy Now, 7/7/2025, According to Top Analysts
4.5
07-03BenzingaCrude Oil Down 1%; Tripadvisor Shares Jump
4.0
07-03BenzingaBarrington Research Maintains Outperform on Franklin Covey, Maintains $35 Price Target
Sign Up For More News
People Also Watch

ESPR
Esperion Therapeutics Inc
1.410
USD
-4.08%

VALU
Value Line Inc
38.450
USD
-0.21%

VBNK
Versabank
11.800
USD
+0.85%

SVC
Service Properties Trust
2.710
USD
-7.51%

MYE
Myers Industries Inc
14.640
USD
-2.59%

URGN
Urogen Pharma Ltd
19.220
USD
+1.69%

BIOX
Bioceres Crop Solutions Corp
3.470
USD
-4.93%

CLDT
Chatham Lodging Trust
6.790
USD
-2.16%

SAGE
SAGE Therapeutics Inc
8.680
USD
-0.23%

ALNT
Allient Inc
39.600
USD
-0.90%
FAQ

What is Franklin Covey Co (FC) stock price today?
The current price of FC is 19.7 USD — it has decreased -2.18 % in the last trading day.

What is Franklin Covey Co (FC)'s business?

What is the price predicton of FC Stock?

What is Franklin Covey Co (FC)'s revenue for the last quarter?

What is Franklin Covey Co (FC)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Franklin Covey Co (FC)'s fundamentals?

How many employees does Franklin Covey Co (FC). have?
